Malek G. Massad

Malek G. Massad

Auto-generated profile, based on publicly available information

Malek G. Massad

Department of Surgery, The University of Illinois at Chicago, 60612, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2005 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
SGSean Garrean
Sean Garrean
MMMalek G. Massad
Malek G. Massad
MTMichael Tshibaka
Michael Tshibaka
ZHZiad Hanhan
Ziad Hanhan
ACAmitra E. Caines
Amitra E. Caines
EBEnrico Benedetti
Enrico Benedetti

12 October 2005 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MMMalek G. Massad
Malek G. Massad
CPCharles R. Powell
Charles R. Powell
JKJacques Kpodonu
Jacques Kpodonu
CTCimenga Tshibaka
Cimenga Tshibaka
ZHZiad Hanhan
Ziad Hanhan
AGAlexander S. Geha
Alexander S. Geha

8 August 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ASArvind Sridhar
Arvind Sridhar
JDJaime DeSantiago
Jaime DeSantiago
HCHanna Chen
Hanna Chen
MPMahmud Arif Pavel
Mahmud Arif Pavel
OLOlivia Ly
Olivia Ly
DDDawood Darbar
Dawood Darbar
Obesity is linked to an increased risk of atrial fibrillation (AF) via increased oxidative stress. While NADPH oxidase 2 (NOX2), a major source of oxidative stress and reactive oxygen species (ROS) in the heart, predisposes to AF, the underlying mechanisms remain unclear. Here, we studied NOX2-mediated ROS production in obesity-mediated AF using Nox2 -knockout mice and mature human induced pluripotent stem cell–derived atrial cardiomyocytes (hiPSC-aCMs). Diet-induced obesity (DIO) mice and hiPSC-aCMs treated with palmitic acid (PA) were infused with a NOX blocker (apocynin) and a NOX2-specific inhibitor, respectively. We showed that NOX2 inhibition normalized atrial action potential duration and abrogated obesity-mediated ion channel remodeling with reduced AF burden. Unbiased transcriptomics analysis revealed that NOX2 mediates atrial remodeling in obesity-mediated AF in DIO mice, PA-treated hiPSC-aCMs, and human atrial tissue from obese individuals by upregulation of paired-like homeodomain transcription factor 2 (PITX2). Furthermore, hiPSC-aCMs treated with hydrogen peroxide, a NOX2 surrogate, displayed increased PITX2 expression, establishing a mechanistic link between increased NOX2-mediated ROS production and modulation of PITX2. Our findings offer insights into possible mechanisms through which obesity triggers AF and support NOX2 inhibition as a potential novel prophylactic or adjunctive therapy for patients with obesity-mediated AF.

8 April 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
OLOlivia T. Ly
Olivia T. Ly
HCHanna Chen
Hanna Chen
GBGrace E. Brown
Grace E. Brown
Liang HongLiang Hong
Liang Hong
XWXinge Wang
Xinge Wang
DDDawood Darbar
Dawood Darbar
Human induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) can model heritable arrhythmias to personalize therapies for individual patients. Although atrial fibrillation (AF) is a leading cause of cardiovascular morbidity and mortality, current platforms to generate iPSC-atrial (a) CMs are inadequate for modeling AF. We applied a combinatorial engineering approach, which integrated multiple physiological cues, including metabolic conditioning and electrical stimulation, to generate mature iPSC-aCMs. Using the patient’s own atrial tissue as a gold standard benchmark, we assessed the electrophysiological, structural, metabolic, and molecular maturation of iPSC-aCMs. Unbiased transcriptomic analysis and inference from gene regulatory networks identified key gene expression pathways and transcription factors mediating atrial development and maturation. Only mature iPSC-aCMs generated from patients with heritable AF carrying the non-ion channel gene ( NPPA ) mutation showed enhanced expression and function of a cardiac potassium channel and revealed mitochondrial electron transport chain dysfunction. Collectively, we propose that ion channel remodeling in conjunction with metabolic defects created an electrophysiological substrate for AF. Overall, our electro-metabolic approach generated mature human iPSC-aCMs that unmasked the underlying mechanism of the first non-ion channel gene, NPPA , that causes AF. Our maturation approach will allow for the investigation of the molecular underpinnings of heritable AF and the development of personalized therapies.

20 July 2010 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
SPSunil M. Prasad
Sunil M. Prasad
SLShuang Li
Shuang Li
JRJ. Scott Rankin
J. Scott Rankin
SOSean M. O’brien
Sean M. O’brien
JGJames S. Gammie
James S. Gammie
MMMalek G. Massad
Malek G. Massad

1 May 2005 in Chest
Verified
Journal Article
Closed access
PDF file
RDRobert J. DiDomenico
Robert J. DiDomenico
MMMalek G. Massad
Malek G. Massad
JKJacques Kpodonu
Jacques Kpodonu
RNR. Antonio Navarro
R. Antonio Navarro
AGAlexander S. Geha
Alexander S. Geha